Durolane 1082020
Durolane 1082020 is a synovial fluid supplementation medium (FDA Class III; FDA product code MOZ, Acid, Hyaluronic, Intraarticular) made by Bioventus LLC, approved under FDA PMA P170007 on 29 Aug 2017 and listed in FDA GUDID since 20 Nov 2017 (UDI-DI 00816986020808), active as of 22 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00816986020808 | Date20 Nov 2017 | StatusListed |
| United States | FDA PMAAPPR | NumberP170007 | Date29 Aug 2017 | StatusActive |
Official records
- AccessGUDID record 00816986020808
- FDA PMA database P170007
From the FDA record
- Device description
- DUROLANE is a clear, transparent, viscous gel of highly purified, stabilized, non-animal-derived sodium hyaluronate that is biosynthesized using bacterial fermentation. NASHA® technology is used to stabilize naturally entangled hyaluronic acid (HA) chains to produce a gel. The gel is suspended in phosphate- buffered saline at a concentration of 20 mg/mL. DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA PMA P170007 decided 29 Aug 2017 Active
- FDA GUDID UDI-DI 00816986020808 listed 20 Nov 2017 Listed
Timeline
- Approved FDA PMA P170007
- Listed FDA GUDID 00816986020808
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Durolane
- Generic name
- Synovial fluid supplementation medium
- Model / Ref / Catalog
- 1082020
- Primary DI / UDI-DI
- 00816986020808
- PMA number
- FDA product code
- MOZ
- GMDN term
- Synovial fluid supplementation medium
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- SYNOJOYNT by Mesoblast
- TriVisc by Channel-Markers Medical, LLC
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.
- TRILURON by Fidia Farmaceutici S.p.A.
- Supartz by Seikagaku Corp.
- Gel-One by Seikagaku Corp.
- GenVisc 850 by Channel-Markers Medical, LLC
- Hymovis High Molecular Weight Viscoelastic Hyaluronan by Fidia Farmaceutici
- Orthovisc High Molecular Weight Hyaluronan by Anika Therapeutics, Inc.
- Hyalgan Acid, Hyaluronic, Intraarticular by Fidia Farmaceutici S.p.A.